We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system.
An overview of the five technologies selected for the AI Airlock pilot.
Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
Guidance on registration of certain in vitro diagnostic devices reliant on expired or expiring CE certificates or declarations of conformity.
Explainer for industry on the main changes introduced by the Windsor Framework on the supply of medicines in Northern Ireland.
Update on MHRA UK risk-based GxP inspection programme.
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
How we engage and involve patients and the public in our regulatory decision-making.
Labelling requirements for e-liquids.
Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore research and technology development of relevance to the modelling of traumatic wounds and the monitoring of their progression.
Information for manufacturers on the regulations that apply to prosthetic, orthotic and ophthalmic devices.
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
Guidance for local partnerships on how to review adult drug and alcohol related deaths and near-fatal overdoses to prevent future deaths.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
This is a work sharing model for the co-ordinated assessment of a generic application that has been filed with multiple Access Consortium agencies.
New Cosmetic Breast Augmentation Risk Awareness Tool for patients to use when considering cosmetic breast implant surgery.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).